CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113516358
- Phone
- (984) 884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-05 | Foundation Fighting Blindness Retinal Degeneration Fund Director | Conversion | +6,927,419 | 9,492,171 | ||
| 2025-05-05 | Foundation Fighting Blindness Retinal Degeneration Fund Director | Conversion · Series A Non-Voting Convertible Preferred Stock | −6,927.42 | 0 | ||
| 2025-04-30 | Rodgers Richard J Director | Grant or award | +79,504 | 318,655 | ||
| 2025-04-30 | Rodgers Richard J Director | Grant or award · Stock Option (Right to Buy) | +79,592 | 79,592 | ||
| 2025-04-30 | MANUSO JAMES S J Director | Grant or award | +79,504 | 261,763 | ||
| 2025-04-30 | MANUSO JAMES S J Director | Grant or award · Stock Option (Right to Buy) | +79,592 | 79,592 | ||
| 2025-04-30 | Graves Adrienne L Director | Grant or award | +79,504 | 79,504 | ||
| 2025-04-30 | Graves Adrienne L Director | Grant or award · Stock Option (Right to Buy) | +79,592 | 79,592 | ||
| 2025-04-30 | Gallagher Cam Director | Grant or award | +79,504 | 940,865 | ||
| 2025-04-30 | Gallagher Cam Director | Grant or award · Stock Option (Right to Buy) | +79,592 | 79,592 | ||
| 2025-04-30 | Benton Susan Director | Grant or award | +79,504 | 219,527 | ||
| 2025-04-30 | Benton Susan Director | Grant or award · Stock Option (Right to Buy) | +79,592 | 79,592 | ||
| 2025-04-30 | Bennett Jean Director | Grant or award | +79,504 | 213,525 | ||
| 2025-04-30 | Bennett Jean Director | Grant or award · Stock Option (Right to Buy) | +79,592 | 79,592 | ||
| 2025-04-30 | Ainsworth Sean Director | Grant or award | +79,504 | 167,862 | ||
| 2025-04-30 | Ainsworth Sean Director | Grant or award · Stock Option (Right to Buy) | +79,592 | 79,592 | ||
| 2025-03-24 | Magrath George Chief Executive Officer | Grant or award | +392,157 | 1,322,004 | ||
| 2025-03-24 | Magrath George Chief Executive Officer | Grant or award · Warrants (right to buy) | +392,157 | 392,157 | ||
| 2025-03-24 | Gallagher Cam Director | Grant or award | +784,314 | 861,361 | ||
| 2025-03-24 | Gallagher Cam Director | Grant or award · Warrants (right to buy) | +784,314 | 784,314 |
Page 4 of 7 · 136 trades